BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures
Clinical trial NCT03474770 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03474770
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2026-12-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.